CID 16130305

D(5'-gctcccgggctcgacc-3') phosphoramidate oligonucleotide

Structural Information

Molecular Formula
C152H211N74O79P15
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(NC3CC(OC3COP(=O)(NC4CC(OC4CO)N5C=NC6=C5N=C(NC6=O)N)O)N7C=CC(=NC7=O)N)O)NP(=O)(O)OCC8C(CC(O8)N9C=CC(=NC9=O)N)NP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)NP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)NP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)NP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)NP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)NP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)NP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)NP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)NP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)NP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)NP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)NP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)N
InChI
InChI=1S/C152H211N74O79P15/c1-60-35-219(151(243)194-131(60)228)110-28-71(87(299-110)46-283-310(253,254)200-65-22-104(213-13-5-96(156)178-145(213)237)292-80(65)39-276-306(245,246)196-63-20-113(290-78(63)37-227)222-55-171-119-126(222)184-138(163)189-133(119)230)204-314(261,262)279-43-84-67(24-106(296-84)215-15-7-98(158)180-147(215)239)199-309(251,252)277-41-82-66(23-105(294-82)214-14-6-97(157)179-146(214)238)198-308(249,250)278-42-83-69(26-108(295-83)217-17-9-100(160)182-149(217)241)202-312(257,258)287-50-91-76(33-116(303-91)225-58-174-122-129(225)187-141(166)192-136(122)233)209-319(271,272)289-52-93-77(34-117(305-93)226-59-175-123-130(226)188-142(167)193-137(123)234)210-320(273,274)288-51-92-74(31-114(304-92)223-56-172-120-127(223)185-139(164)190-134(120)231)207-317(267,268)282-45-86-68(25-107(298-86)216-16-8-99(159)181-148(216)240)201-311(255,256)284-47-88-72(29-111(300-88)220-36-61(2)132(229)195-152(220)244)205-315(263,264)280-44-85-70(27-109(297-85)218-18-10-101(161)183-150(218)242)203-313(259,260)286-49-90-75(32-115(302-90)224-57-173-121-128(224)186-140(165)191-135(121)232)208-318(269,270)285-48-89-73(30-112(301-89)221-54-170-118-124(162)168-53-169-125(118)221)206-316(265,266)281-40-81-64(21-103(293-81)212-12-4-95(155)177-144(212)236)197-307(247,248)275-38-79-62(153)19-102(291-79)211-11-3-94(154)176-143(211)235/h3-18,35-36,53-59,62-93,102-117,227H,19-34,37-52,153H2,1-2H3,(H2,154,176,235)(H2,155,177,236)(H2,156,178,237)(H2,157,179,238)(H2,158,180,239)(H2,159,181,240)(H2,160,182,241)(H2,161,183,242)(H2,162,168,169)(H,194,228,243)(H,195,229,244)(H2,196,245,246)(H2,197,247,248)(H2,198,249,250)(H2,199,251,252)(H2,200,253,254)(H2,201,255,256)(H2,202,257,258)(H2,203,259,260)(H2,204,261,262)(H2,205,263,264)(H2,206,265,266)(H2,207,267,268)(H2,208,269,270)(H2,209,271,272)(H2,210,273,274)(H3,163,184,189,230)(H3,164,185,190,231)(H3,165,186,191,232)(H3,166,187,192,233)(H3,167,188,193,234)
InChIKey
MKKDKXCDQRANRU-UHFFFAOYSA-N
Compound name
[3-amino-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-N-[2-[[[[2-[[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[[2-[[[[2-[[[[2-[[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[[2-[[[[2-[[[[2-[[[[2-[[[[2-[[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-yl]amino]-hydroxyphosphoryl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]amino]-hydroxyphosphoryl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]amino]-hydroxyphosphoryl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]amino]-hydroxyphosphoryl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]amino]-hydroxyphosphoryl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]amino]-hydroxyphosphoryl]oxymethyl]oxolan-3-yl]amino]-hydroxyphosphoryl]oxymethyl]oxolan-3-yl]amino]-hydroxyphosphoryl]oxymethyl]oxolan-3-yl]amino]-hydroxyphosphoryl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]amino]-hydroxyphosphoryl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]amino]-hydroxyphosphoryl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]amino]-hydroxyphosphoryl]oxymethyl]oxolan-3-yl]amino]-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)oxolan-3-yl]amino]-hydroxyphosphoryl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]phosphonamidic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

4801.083 Da
Monoisotopic Mass

-41.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 4802.0903 311.6
[M+Na]+ 4824.0722 311.6
[M-H]- 4800.0757 311.6
[M+NH4]+ 4819.1168 311.6
[M+K]+ 4840.0462 311.6
[M+H-H2O]+ 4784.0803 311.6
[M+HCOO]- 4846.0812 311.6
[M+CH3COO]- 4860.0969 311.6
[M+Na-2H]- 4822.0577 311.7
[M]+ 4801.0825 311.6
[M]- 4801.0835 311.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.